Iranian scientists at Royan Institute for Reproductive Biomedicine, Stem Cell Biology and Technology managed to produce a new type of drug from goat milk for treating patients who have just had a heart failure.
“We managed to produce the drug to treat myocardial infarction (heart failure) and the medicine which has reached the laboratory production stage is produced from goat’s milk and we hope that it will reach the stage of industrial (mass-) production,” Head of Royan Institute Mohammad Hossein Nasr Esfahani said in the Central city of Isfahan on Wednesday.
“The patients will not need to be hospitalized after a heart failure and actually the drug clears blood clots,” he added.
Royan Institute for Reproductive Biomedicine, Stem Cell Biology and Technology is a leading Iranian biomedical research center involved in stem cell technology and regenerative medicine.
The institute was established in 1991. Its first director was Professor Saeid Kazzemi Ashtiani. Since its establishment, the institute has had close collaborations with other leading Iranian research centers as Institute of Biochemistry and Biophysics (IBB), NRCGEB, Bone Marrow Transplantation Center at Shariati hospital in Tehran.
The Department of Stem Cells was established in 2002 to establish embryonic stem cell lines and to differentiate them to some different kinds of cells including: Cardiomyocytes, Beta Cells, and Neural Cells.
Royan is a leading stem cell research center in Asia and Middle-East too.
Scientists at the stem cell department of Iran’s Royan Research Center successfully produced a mouse using embryonic stem cells.
The mouse was created by injecting the embryonic stem cells of a black mouse into a white mouse’s blastosists.
The resulted embryos were then transferred to another mouse’s uterine and finally a chimera mouse was born, he continued.
In 2006, Royan Research Center scientists successfully cloned the country’s first lamb, Royana.